| Antigen | 28-aa peptide of Human D2R ; Designated (D2R13-P or control peptide /blocking peptide) conjugated to KLH.
Epitope location. ~ N-terminal, Cytoplasmic |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | Human D2R13-P peptide was specific for D2R. No significant sequence homology is seen with other dopamine receptors (D1 and D3-D5). It is 100% homologous with human/bovine/dog, and 50% with Xenopus D2 receptors. Antibodies generated to the human sequence have been shown to recognize the canine D2R (2). Antibody crossreactivity with D2 receptors from various species is not known. |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |